Outcome in dilated cardiomyopathy related to the extent, location, and pattern of late gadolinium enhancement

Halliday, Brian P., Baksi, A. John, Gulati, Ankur, Ali, Aamir, Newsome, Simon, Izgi, Cemil, Arzanauskaite, Monika, Lota, Amrit, Tayal, Upasana, Vassiliou, Vassilios S. ORCID: https://orcid.org/0000-0002-4005-7752, Gregson, John, Alpendurada, Francisco, Frenneaux, Michael P., Cook, Stuart A., Cleland, John G.F., Pennell, Dudley J. and Prasad, Sanjay K. (2019) Outcome in dilated cardiomyopathy related to the extent, location, and pattern of late gadolinium enhancement. JACC: Cardiovascular Imaging, 12 (8 Part 2). pp. 1645-1655. ISSN 1936-878X

[thumbnail of Proof]
Preview
PDF (Proof)
Available under License Creative Commons Attribution.

Download (1MB) | Preview
[thumbnail of Published_Version]
Preview
PDF (Published_Version) - Published Version
Available under License Creative Commons Attribution.

Download (964kB) | Preview

Abstract

Objectives: This study sought to investigate the association between the extent, location, and pattern of late gadolinium enhancement (LGE) and outcome in a large dilated cardiomyopathy (DCM) cohort. Background: The relationship between LGE and prognosis in DCM is incompletely understood. Methods: The authors examined the association between LGE and all-cause mortality and a sudden cardiac death (SCD) composite based on the extent, location, and pattern of LGE in DCM. Results: Of 874 patients (588 men, median age 52 years) followed for a median of 4.9 years, 300 (34.3%) had nonischemic LGE. Estimated adjusted hazard ratios for patients with an LGE extent of 0 to 2.55%, 2.55% to 5.10%, and >5.10%, respectively, were 1.59 (95% confidence interval [CI]: 0.99 to 2.55), 1.56 (95% CI: 0.96 to 2.54), and 2.31 (95% CI: 1.50 to 3.55) for all-cause mortality, and 2.79 (95% CI: 1.42 to 5.49), 3.86 (95% CI: 2.09 to 7.13), and 4.87 (95% CI: 2.78 to 8.53) for the SCD endpoint. There was a marked nonlinear relationship between LGE extent and outcome such that even small amounts of LGE predicted a substantial increase in risk. The presence of septal LGE was associated with increased mortality, but SCD was most associated with the combined presence of septal and free-wall LGE. Predictive models using LGE presence and location were superior to models based on LGE extent or pattern. Conclusions: In DCM, the presence of septal LGE is associated with a large increase in the risk of death and SCD events, even when the extent is small. SCD risk is greatest with concomitant septal and free-wall LGE. The incremental value of LGE extent beyond small amounts and LGE pattern is limited.

Item Type: Article
Uncontrolled Keywords: cardiovascular magnetic resonance,dilated cardiomyopathy,late gadolinium enhancement
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
UEA Research Groups: Faculty of Medicine and Health Sciences > Research Groups > Cardiovascular and Metabolic Health
Faculty of Science > Research Groups > Norwich Epidemiology Centre
Faculty of Medicine and Health Sciences > Research Groups > Norwich Epidemiology Centre
Faculty of Medicine and Health Sciences > Research Centres > Metabolic Health
Related URLs:
Depositing User: LivePure Connector
Date Deposited: 18 Sep 2018 09:31
Last Modified: 19 Oct 2023 02:16
URI: https://ueaeprints.uea.ac.uk/id/eprint/68308
DOI: 10.1016/j.jcmg.2018.07.015

Downloads

Downloads per month over past year

Actions (login required)

View Item View Item